Serum Levels of Nesfatin-1 and Irisin in Obese Children
Overview
Affiliations
Along with the developing technology in the modern age, physical activity had decreased considerably in children and adolescents alike with a concomittant and rapid increase in the prevalence of childhood obsesity. The purpose of the present study is to measure the levels of serum nesfatin-1 and irisin in obese children. The present study was carried out with a total of 62 children, including 32 obese children diagnosed between June 2017 and October 2017 and 30 healthy children. Serum nesfatin-1, irisin, SOD, MDA, fasting blood glucose, total cholesterol (TC), triglyceride (TG), HDL-C, LDL-C, aspartate amino transferase (AST), alanine amino transferase (ALT)), blood urea nitrogen (BUN), C-reactive protein (CRP), calcium (Ca), sodium (Na), potassium (P), chromium (Cr), ferritin, and vitamin B data were collected for each patient. In our study, mean nesfatin-1 and SOD values of the obesity group were lower than those of the control group (p <0.05, p <0.001), whereas irisin and MDA values were higher than those of the control group (p <0.001). Childhood obesity is still a significant global problem, despite increased social awareness and numerous preventive healthcare interventions. We believe that all the prospective studies to be carried out to evaluate the relationship between obesity-irisin-nesfatin-1 triad, will make positive contributions to treatment of obesity.
Herouvi D, Vlachopapadopoulou E, Vakaki M, Gouriotis D, Marmarinos A, Kalpia C Endocrine. 2024; 87(3):1031-1040.
PMID: 39725768 DOI: 10.1007/s12020-024-04139-x.
Nesfatin-1: A Novel Diagnostic and Prognostic Biomarker in Digestive Diseases.
Damian-Buda A, Matei D, Ciobanu L, Damian-Buda D, Pop R, Buzoianu A Biomedicines. 2024; 12(8).
PMID: 39200377 PMC: 11352118. DOI: 10.3390/biomedicines12081913.
Shen X, Chen Y, Zhang J, Yang M, Huang L, Luo J Front Endocrinol (Lausanne). 2024; 15:1388717.
PMID: 39175571 PMC: 11338845. DOI: 10.3389/fendo.2024.1388717.
Pelczynska M, Miller-Kasprzak E, Piatkowski M, Mazurek R, Klause M, Suchecka A Antioxidants (Basel). 2023; 12(12).
PMID: 38136166 PMC: 10740719. DOI: 10.3390/antiox12122046.
Esin K, Batirel S, Ulfer G, Yigit P, Sanlier N Medicina (Kaunas). 2023; 59(11).
PMID: 38004003 PMC: 10673282. DOI: 10.3390/medicina59111954.